3-Isopropyl-1-methylpiperidin-4-amine dihydrochloride, 95.0%, 250mg

(4-Aminotetrahydro-2H-pyran-4-yl)methanol, 95.0%, 100mg

(2E)-1-{[1,1'-biphenyl]-4-yl}-3-(2-fluorophenyl)prop-2-en-1-one, 95.0%, 2g

5-((1,4-Diazepan-1-yl)sulfonyl)isoquinolin-1(2H)-one, 95.0%, 50mg

(S)-N-BOC-2,2-DIMETHYL-4-VINYLOXAZOLIDINE, 97.0%, 250mg

(S)-alpha,alpha-Bis[3,5-bis(trifluoromethyl)phenyl]-2-pyrrolidinemethanol>98.0%(GC)(T)1g

Methyl 4-morpholinecarbodithioate, 95+%, 100mg

ethyl N-(2-methylphenyl)glycinate, 1g

Imidazo[1,2-a]pyridine-5-carboxylic acid, 95.0%, 2.5g

silla de trabajo, patas corredizas, con reposapiés 1ud

Ethylene Glycol Mono-tert-butyl Ether>99.0%(GC)500mL

Pyr3, 99.90%, 250mg